Litcius/Paper detail

Comparison of BNT162b2 (Pfizer–BioNtech) and mRNA-1273 (Moderna) SARS-CoV-2 mRNA vaccine immunogenicity in dialysis patients

Robert A. Kaiser, Maria Haller, Petra Apfalter, Heidrun Kerschner, Daniel Cejka

2021Kidney International34 citationsDOIOpen Access PDF

Topics & Concepts

MedicineImmunogenicityVaccinationDialysisAntibodyHemodialysisSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)ImmunologyVirologyInternal medicineDiseaseInfectious disease (medical specialty)SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesCOVID-19 Impact on Reproduction
Comparison of BNT162b2 (Pfizer–BioNtech) and mRNA-1273 (Moderna) SARS-CoV-2 mRNA vaccine immunogenicity in dialysis patients | Litcius